Associated Papers
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies.
Flümann R et al.
Blood Cancer Discovery, 2023
36346827 (PubMed )
Supplement: bcd-22-0007_table_s6_suppst6.xlsx › C_Mut_Pat.__2
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia.
Herling CD et al.
Nature Communications, 2018
29463802 (PubMed )
Supplement: 41467_2018_3170_MOESM4_ESM.xlsx › Clonal_Composition
Select a paper to view details